148 related articles for article (PubMed ID: 32831024)
1. Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran.
Mirzaei-Alavijeh M; Jalilian F; Solaimanizadeh L; Saadatfar A; Khashij S; Pirouzeh R; Solaimanizadeh F
BMC Geriatr; 2020 Aug; 20(1):298. PubMed ID: 32831024
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study.
Young GJ; Harrison S; Turner EL; Walsh EI; Oliver SE; Ben-Shlomo Y; Evans S; Lane JA; Neal DE; Hamdy FC; Donovan JL; Martin RM; Metcalfe C
BMJ Open; 2017 Oct; 7(10):e017729. PubMed ID: 29084797
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
Morlando M; Pelullo CP; Di Giuseppe G
PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
Dyche DJ; Ness J; West M; Allareddy V; Konety BR
J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
Williams N; Hughes LJ; Turner EL; Donovan JL; Hamdy FC; Neal DE; Martin RM; Metcalfe C
BJU Int; 2011 Nov; 108(9):1402-8. PubMed ID: 21481132
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
[TBL] [Abstract][Full Text] [Related]
9. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
10. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
11. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran.
Safarinejad MR
Ann Oncol; 2006 Jul; 17(7):1166-71. PubMed ID: 16684791
[TBL] [Abstract][Full Text] [Related]
12. [Prostate cancer screening with Prostate-Specific Antigen (PSA) to men over 70 years old in an urban health zone, 2018-2020: A cross-sectional study].
Urquijo-Moraza A; Guinea-Castañares J; Iturralde-Iriso JM
Semergen; 2023; 49(1):101876. PubMed ID: 36462252
[TBL] [Abstract][Full Text] [Related]
13. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
[TBL] [Abstract][Full Text] [Related]
14. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.
Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653
[TBL] [Abstract][Full Text] [Related]
15. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
16. Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK.
Down L; Barlow M; Bailey SER; Mounce LTA; Merriel SWD; Watson J; Martins T
BMC Med; 2024 Mar; 22(1):82. PubMed ID: 38424555
[TBL] [Abstract][Full Text] [Related]
17. Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Harrison S; Tilling K; Turner EL; Lane JA; Simpkin A; Davis M; Donovan J; Hamdy FC; Neal DE; Martin RM
Cancer Causes Control; 2016 Dec; 27(12):1465-1474. PubMed ID: 27830401
[TBL] [Abstract][Full Text] [Related]
18. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
Molazem Z; Ebadi M; Khademian M; Zare R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study.
Ruan X; Zhang N; Wang D; Huang J; Huang J; Huang D; Chun TTS; Ho BSH; Ng AT; Tsu JH; Zhan Y; Na R
JMIR Public Health Surveill; 2024 Jan; 10():e47161. PubMed ID: 38236627
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.
Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
Urology; 2010 Nov; 76(5):1058-62. PubMed ID: 20035982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]